As the obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a ...

The trial is funded in part by a $30m grant from the US Biomedical Advanced Research and Development Authority (BARDA).

Clario and PathAI partnered to offer an integrated solution for enhancing efficiency of gastrointestinal (GI) clinical trials ...

Pfizer has announced data from the Phase III trial of TALZENNA plus XTANDI in patients with metastatic castration-resistant ...

Cassava alleged that the short sellers had launched a “short and distort” campaign which caused a “decline in Cassava ...

The technology is part of a broader industry shift towards precision medicine, says GlobalData analyst Cynthia Stinchcombe.

Viking Therapeutics has announced positive results from its Phase Ib trial of VK0214 in patients with X-linked ...

DiaMedica Therapeutics has received the SAHPRA approval to commence a Phase II trial of DM199 to treat preeclampsia.

Chicago-based Vanqua Bio’s Parkinson’s disease drug has shown proof-of-concept in a first-in-human study, with the company to ...

Allurion has added more efficacy and safety data to support its intragastric balloon, but popularity of GLP-1 drugs shows no ...

InnoCare Pharma has announced that its Phase II study of the TYK2 inhibitor ICP-488 for psoriasis treatment met the primary ...

The company plans to study the application of molecular residual disease (MRD) testing in breast cancer management using its ...